Variability of the recessive oculopharyngeal muscular dystrophy phenotype

Oculopharyngeal muscular dystrophy (OPMD) is usually transmitted as an autosomal‐dominant trait and characterized by an expansion from 6 to 8 or more GCG/GCA repeats in the poly‐(A) binding protein nuclear 1 (PABPN1) gene on chromosome 14q11. Autosomal‐recessive OPMD with a homozygous (GCG)7 expansion of PABPN1 has only been described in two Canadian patients, who showed a comparably mild phenotype, suggesting that it is less severe than the dominant form. We clinically and genetically characterized the first two reported cases of autosomal‐recessive OPMD in Europe. Remarkably, both patients revealed severe and diverse phenotypes, with an unusual onset and atypical clinical course in one patient. Former studies found a 1%–2% frequency of the (GCG)7 allele, which theoretically produces an incidence of 1:10,000 of autosomal‐recessive OPMD in the general population. We conclude that the apparent rarity of the autosomal‐recessive form of OPMD may be due to the fact that genetic testing is generally administered only to patients with typical clinical features or a positive family history. Muscle Nerve, 2007

[1]  S. Zierz,et al.  Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy , 2006, Journal of Neurology.

[2]  G. van Ommen,et al.  Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody. , 2006, Human molecular genetics.

[3]  D. Robinson,et al.  Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism , 2005, Human Genetics.

[4]  B. Brais Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease , 2003, Cytogenetic and Genome Research.

[5]  Mika Nakamoto,et al.  Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy. , 2002, Archives of neurology.

[6]  W. Kress,et al.  Unusual triplet expansion associated with neurogenic changes in a family with oculopharyngeal muscular dystrophy , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[7]  D. Robinson,et al.  Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population. , 2001, Brain : a journal of neurology.

[8]  S. Di Giovanni,et al.  GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy , 2000, Neurology.

[9]  S. Blumen,et al.  Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease , 1999, Annals of neurology.

[10]  J. Rommens,et al.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.

[11]  J. Weissenbach,et al.  The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac α and β myosin heavy chain genes on chromosome 14q11.2−q13 , 1995 .

[12]  J. Weissenbach,et al.  The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. , 1995, Human molecular genetics.